4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow ceftobiprole: new trials by email Literature Review of ceftobiprole trials Research Report on ceftobiprole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections ceftobiprole medocaril, vancomycin+aztreonam - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Basilea Pharmaceutica | 679 | 2018-02-19 | 2026-09-18 |
| Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia ceftobiprole medocaril, IV standard-of-care cephalosporin - Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP) | Phase 3 | Completed | Basilea Pharmaceutica | 138 | 2017-11-27 | 2023-05-12 |
| Ceftobiprole in Hospital Acquired Pneumonia ceftobiprole plus placebo, linezolid plus ceftazidime - Pneumonia | Phase 3 | Completed | Basilea Pharmaceutica | 106 | 2005-11-01 | 2012-09-03 |
| Ceftobiprole in Hospital Acquired Pneumonia ceftobiprole plus placebo, linezolid plus ceftazidime - Pneumonia | Phase 3 | Completed | Basilea Pharmaceutica | 781 | 2005-04-01 | 2012-09-03 |
Healthcare-Associated Pneumonia (2) · Pneumonia (2) · Pneumonia, Ventilator-Associated (2) · Community-Acquired Pneumonia (1)
Bulgaria (2) · Hungary (2) · Georgia (1) · Romania (1) · Ukraine (1) · United States (1)
PMID 33960817, PMID 24723282, PMID 30808293, PMID 34155899, PMID 41251370, PMID 32897367, PMID 33480665, PMID 34533489